Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Anthrax future or investigational therapies
Introduction
Overview
Overview
Given the safety and efficacy of current vaccines and antibiotics, there are not a large number of new agents under development to treat anthrax.
Newer Agents
Newer Agents
In recent years there have been many attempts to develop additional new drugs to prevent anthrax; however the existing supply of current antibiotics is effective if treatment is initiated soon after infection has occurred.
In May 2009, Human Genome Sciences submitted a Biologic License Application (BLA, permission to market) for its new drug, raxibacumab (brand name ABthrax) intended for emergency treatment of inhaled anthrax.[1]
References
References
- ↑ “HGSI asks for FDA approval of anthrax drug ABthrax”. Forbes. Associated Press. 21 May 2009.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]